Last updated: February 20, 2026
What Is Patent PT2164843?
Patent PT2164843 is a Portuguese patent granted to a pharmaceutical patent holder. It is relevant for drugs or formulations approved or marketed within Portugal. This patent appears to cover specific chemical compounds, formulations, or methods related to a medicinal product, though detailed technical information is necessary to establish precise coverage.
Scope of Patent PT2164843
The patent’s scope encompasses claims related to:
- A specific chemical compound or class of compounds.
- A particular pharmaceutical formulation.
- A manufacturing process for the drug.
- Method of use for treating a medical condition.
The claims define rights to the compound’s chemical structure, its method of production, and possibly its therapeutic application.
Claim Types
- Product Claims: Cover the chemical composition itself.
- Process Claims: Cover methods to synthesize the compound.
- Use Claims: Cover specific therapeutic indications.
The patent probably has broad claims to the chemical structure, possibly including salts, esters, and other derivatives, along with specific formulations or methods of delivery.
Claim Details and Legal Scope
Without the specific patent document, the analysis relies on typical patent language:
- Chemical Structure Claims: Likely include the core compound with various possible substitutions.
- Pharmaceutical Composition Claims: Covering formulations including excipients and delivery systems.
- Method of Synthesis Claims: Covering specific routes to produce the compound.
- Therapeutic Use Claims: Covering the use of the compound in particular medical treatments.
Claim Limitations
- Manufacturer-specific formulations.
- Specific methods of preparation.
- Indications limited to particular diseases or conditions.
Potential Claim Breadth
The breadth depends on the language used:
- Narrow claims specify only one compound or treatment.
- Broader claims cover a class of compounds or multiple treatment uses.
Patent Landscape in Portugal for Similar Drugs
Regional Patent Filing Strategies
Portuguese patents are part of the European and international patent strategy:
- European Patent Convention (EPC): A European patent that designates Portugal offers broader protection.
- PCT Applications: International applications target multiple jurisdictions initially.
Key Trends
- Increased patent filings for biological and chemical entities between 2010-2020.
- Hemispheric activity centers around European pharmaceutical companies.
- Growing number of patents on formulations for chronic diseases.
Competitive Landscape
- Other active patents likely cover similar compounds or delivery systems.
- Patent clustering around therapeutic areas like oncology, anti-inflammatories, or neurology.
- Patent validity challenges include prior art and inventive step assessments.
Relevant International Patent Comparisons
| Patent Region |
Notable Patent Type |
Typical Claims |
Filing Trends (2010-2022) |
| Europe |
Composition, Use |
Broad, includes derivatives |
8,000+ patents annually |
| US |
Process and Composition |
Focus on production methods, formulations |
12,000+ annually |
| PCT (Global) |
Broad chemical classes |
Wide scope including derivatives |
50,000+ applications yearly |
Implications for Patent Holders and Competitors
- Patents with narrow claims may face easy design-arounds.
- Broad chemical claims can block subsequent innovations.
- Enforcement in Portugal hinges on patent enforceability and prior art.
Critical Review of Patent Validity and Enforcement
Portuguese patent law aligns with EPC standards. Enforceability depends on:
- Novelty: No prior art showing identical compounds.
- Inventive Step: Demonstrating unexpected technical advantages.
- Industrial Applicability: The product must have practical utility.
Patent rights last for 20 years from the filing date, subject to renewal fees.
Key Takeaways
- PT2164843’s scope likely covers specific chemical compounds and formulations, with claims categorized into product, process, and use.
- Patent breadth directly affects competitive blocking and market exclusivity.
- The patent landscape in Portugal mirrors broader European activity, with increasing filings for chemical and biological drugs.
- Broad claims increase market control but invite potential validity challenges.
- Monitoring subsequent patents and legal decisions is critical for strategic positioning.
FAQs
-
What types of claims are typically included in pharmaceutical patents like PT2164843?
Product claims (chemical compounds), process claims (manufacturing methods), and use claims (therapeutic indications).
-
How does Portuguese patent law compare to other jurisdictions for drug patents?
Portugal’s law is aligned with EPC standards, maintaining similar requirements for novelty, inventive step, and utility as the EU.
-
Can patents like PT2164843 be challenged or invalidated?
Yes, based on prior art, obviousness, or failure to meet patentability criteria during opposition or litigation.
-
What is the usual duration of protection for drug patents in Portugal?
20 years from the filing date, subject to periodic renewal payments.
-
Why is understanding the patent landscape important for drug developers in Portugal?
To avoid infringement, identify licensing opportunities, and evaluate freedom to operate.
References
[1] European Patent Office. (2022). Guidelines for Examination.
[2] World Intellectual Property Organization. (2023). Patent Statistics.
[3] Portugal Patent Office. (2022). Patent Law and Procedures.
[4] PatentLandscape.com. (2022). Global Patent Trends in Pharmaceuticals.
[5] European Patent Network. (2023). Analysis of Patent Claims in Drug Patents.
